OPL 0.00% 1.9¢ opyl limited

Ann: Opyl - Business Update & Appendix 4C, page-10

  1. 130 Posts.
    lightbulb Created with Sketch. 12
    Patient recruitment is a significant problem in biopharma. It’s one of the major reasons why trials are delayed. This co can really contribute in solving this problem.

    they have 1.13mill in funding (loan facility + cash). Net spend this quarter was high, should be a profitable quarter going forward potentially with the previous + upcoming contracts they are going to sign
 
watchlist Created with Sketch. Add OPL (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $3.243M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $5.372K 272.1K

Buyers (Bids)

No. Vol. Price($)
1 79814 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 40003 1
View Market Depth
Last trade - 12.49pm 16/08/2024 (20 minute delay) ?
OPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.